The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.

Former club captain Barry Roche leaves Morecambe after 17 years at the Shrimps that spanned both playing and coaching roles.

Alainy Chiloh Roché is ready to tee up for a career in medicine or real estate development, but she will continue to improve ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...

With fewer than 200 trained dermatologists serving Malaysia's 33 million people[1]-just one specialist for every 165,000 ...

Venclexta, when combined with azacitidine, elicited an overall survival benefit below 10% in patients with myelodysplastic ...

From broccoli to booze to Brie, nothing makes presidents seem more like regular people than the arbitrary and utterly ...

Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

Roche and Prothena are forging ahead to late-stage studies for their investigational Parkinson’s disease antibody ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

Roche entered into a Licensing, Development, and Commercialisation agreement with Prothena in December 2013 to develop and ...

Prothena Corporation plc (NASDAQ:PRTA) is an Ireland-based late-stage clinical biotechnology company that identifies and ...